GEO
GEO GroupAAI scenario view
RankAlpha Sentiment CodexAI sentiment snapshot
AI commentary
Primary-company evidence is constructive because the May 6 release was a beat-and-raise and secondary market coverage reported a roughly 20% post-release jump. Even so, analyst revision and target-change evidence is thin, so this remains an execution-and-follow-through monitor rather than a confirmed rerating.
Evidence flagged
No evidence quality warning is currently attached to this memo.
AI events
The May 6 press release/8-K said GEO posted Q1 revenue of $705.2 million, net income attributable to GEO Operations of $38.3 million ($0.29 per diluted share), and Adjusted EBITDA of $131.4 million, then raised FY26 revenue guidance to $2.95 billion-$3.10 billion and FY26 Adjusted EBITDA guidance to $525 million-$545 million while guiding Q2 revenue to $715 million-$725 million and Q2 Adjusted EBITDA to $130 million-$135 million. Secondary market coverage described a roughly 20% post-release jump, so the near-term question is whether Q2 confirms the raised outlook [#8-K-2026-05-06].
Management highlighted the scheduled July 1, 2026 transition of the 1,884-bed Graceville Facility and the 985-bed Bay Facility to GEO management. Clean staffing, occupancy ramp, and margin execution would convert those contract wins into visible second-half revenue rather than only future opportunity [#8-K-2026-05-06].
GEO ended Q1 with about $80 million of cash, about $1.61 billion of debt, net debt of about $1.53 billion, and net leverage below 3.2x trailing Adjusted EBITDA, while repurchasing about $50 million of stock in the quarter. If operating momentum continues, that balance-sheet setup can support deleveraging plus ongoing capital returns over the rest of 2026 [#8-K-2026-05-06] [#10-Q-2026-05-07].
Recommendation
No formal recommendation provided.

